Cardinal Health (NYSE:CAH) Releases FY 2025 Earnings Guidance

by · The Cerbat Gem

Cardinal Health (NYSE:CAH – Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 7.750-7.900 for the period, compared to the consensus earnings per share estimate of 7.630. The company issued revenue guidance of -. Cardinal Health also updated its FY25 guidance to $7.75-7.90 EPS.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CAH shares. Citigroup dropped their target price on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. Mizuho boosted their price target on shares of Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Argus upped their target price on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $123.00.

Get Our Latest Research Report on CAH

Cardinal Health Stock Performance

Shares of NYSE:CAH traded down $3.97 during midday trading on Monday, reaching $112.16. The company’s stock had a trading volume of 2,210,645 shares, compared to its average volume of 2,074,054. The firm has a 50 day moving average price of $111.75 and a two-hundred day moving average price of $104.17. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $119.13. The firm has a market capitalization of $27.14 billion, a price-to-earnings ratio of 22.07, a PEG ratio of 1.49 and a beta of 0.60.

Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.24. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same period last year, the company posted $1.73 earnings per share. Cardinal Health’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, research analysts anticipate that Cardinal Health will post 7.61 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st were paid a $0.506 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend was Tuesday, October 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 39.30%.

Insider Buying and Selling

In other news, insider Jessica L. Mayer sold 17,896 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares in the company, valued at $10,065,447.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, insider Jessica L. Mayer sold 17,896 shares of the firm’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the transaction, the insider now directly owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Aaron E. Alt sold 2,323 shares of Cardinal Health stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.91, for a total value of $252,997.93. Following the completion of the transaction, the chief financial officer now owns 36,867 shares of the company’s stock, valued at approximately $4,015,184.97. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 113,963 shares of company stock valued at $12,379,980 over the last three months. 0.09% of the stock is owned by company insiders.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also